Home » Topics » Regulatory » Patents

Patents
RSS

COX-2 inhibitors from Merck Frosst

June 28, 1996

Merck & Co. claims process for synthesizing HIV protease inhibitors

June 28, 1996

Antifungal agents revealed by Merck & Co.

June 28, 1996

Antibacterial agents revealed by Wakunaga

June 28, 1996

Pharmacia & Upjohn reveal antimicrobial phenyloxazolidinones

June 28, 1996

Fujisawa discloses bradykinin antagonists

June 28, 1996

Teikoku Hormone reveals novel octadecapeptide

June 21, 1996

Lilly discloses insulin analogues

June 21, 1996

Anakinra claimed for pancreatitis

June 21, 1996

Genelabs Technologies describes hepatitis E virus

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...